Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inogen Inc Director's Dealing 2015

Dec 2, 2015

33625_dirs_2015-12-02_363782df-d0e5-4e38-b204-e9c1ff416923.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Inogen Inc (INGN)
CIK: 0001294133
Period of Report: 2015-11-30

Reporting Person: Myers Byron (Vice President, Marketing)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-11-30 Common Stock M 8334 $0.60 Acquired 48185 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-11-30 Stock Option (right to buy) $0.60 M 8334 Disposed 2020-02-24 Common Stock (8334) Direct

Footnotes

F1: Subject to the reporting person's continuing service, sixty percent (60%) of the shares subject to the option shall vest and become exercisable on the vesting commencement date, and thereafter, one thirtieth (1/30th) of the remaining shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the thirty (30) month anniversary of the vesting commencement date. The vesting commencement date for this option is February 24, 2010. This option is fully vested as of August 24, 2012.